Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market

MarketBeat

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.

5 days